quinoxalines has been researched along with atrial natriuretic factor in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (10.00) | 18.7374 |
1990's | 2 (10.00) | 18.2507 |
2000's | 13 (65.00) | 29.6817 |
2010's | 2 (10.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Faber, JE; Gettes, DR; Gianturco, DP | 1 |
Hair, WM; Hughes, AD; Martin, GN; Nielsen, H; Schachter, M; Sever, PS; Thom, SA | 1 |
Coste, H; Grondin, P | 1 |
Campbell, WB; Drewett, JG; Hanke, CJ; Myers, CR | 1 |
Axer, H; Steinbusch, HW; Teunissen, CE | 1 |
Diamond, J; Hennan, JK | 1 |
Bessard, G; Bréant, D; Caron, F; Corompt, E; Devillier, P | 1 |
Gao, Y; Moessinger, A; Raj, JU; Sander, FC; Souici, AC; Tolsa, JF | 1 |
Castañeda-Hernández, G; Granados-Soto, V; Ortiz, MI; Rosas, R; Torres-López, JE; Vidal-Cantú, GC | 1 |
Hobbs, AJ; MacAllister, RJ; Madhani, M; Scotland, RS | 1 |
Cho, KW; Cui, X; Jin, JY; Kim, SH; Kim, SM; Kim, SZ; Lee, HS; Wen, JF | 1 |
Andersen, CU; Mulvany, MJ; Simonsen, U | 1 |
Chan, SL; Chan, SS; Fiscus, RR; Fraser, M; Tsang, BK | 1 |
Gutkowska, J; Menaouar, A; Mukaddam-Daher, S | 1 |
Ahluwalia, A; Hobbs, AJ; Kemp-Harper, B; Madhani, M; Nobles, M; Panayiotou, CM; Scotland, RS; Sheraz, A; Villar, IC | 1 |
Chen, J; Fan, F; Han, L; Wang, S; Wang, X; Xie, X; Yan, J; Zhou, X | 1 |
de Vente, J; Diederen, RM; Hendrikse, F; La Heij, EC; Markerink-van Ittersum, M | 1 |
Fiscus, RR; Wong, JC | 1 |
Kang, YH; Morgan, KG; Shin, HM; Yang, IJ | 1 |
Clark, BJ; El-Mallakh, RS; Gao, Y; Hamlyn, JM; Tegin, G | 1 |
20 other study(ies) available for quinoxalines and atrial natriuretic factor
Article | Year |
---|---|
Microvascular effects of atrial natriuretic factor: interaction with alpha 1- and alpha 2-adrenoceptors.
Topics: Animals; Arterioles; Atrial Natriuretic Factor; Brimonidine Tartrate; Microcirculation; Norepinephrine; Osmolar Concentration; Phenylephrine; Quinoxalines; Vasoconstriction; Vasodilation; Venules | 1988 |
Size and site-dependent heterogeneity of human vascular responses in vitro.
Topics: Arteries; Atrial Natriuretic Factor; Azepines; Brimonidine Tartrate; Calcitonin Gene-Related Peptide; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Neuropeptide Y; Neuropeptides; Phenylephrine; Quinoxalines; Vascular Resistance; Vasoactive Intestinal Peptide | 1988 |
Characterization of a novel potent and specific inhibitor of type V phosphodiesterase.
Topics: Allopurinol; Animals; Atrial Natriuretic Factor; Cattle; Cyclic AMP; Cyclic GMP; Imidazoles; Isoenzymes; Muscle, Smooth, Vascular; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Quinoxalines; Rats; Sensitivity and Specificity; Stimulation, Chemical | 1995 |
Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Bacterial Toxins; Cattle; Cells, Cultured; Cyclic GMP; Enterotoxins; Escherichia coli Proteins; Guanylate Cyclase; Humans; Nitric Oxide; Nitroso Compounds; Oxadiazoles; Pregnenolone; Quinoxalines; Zona Glomerulosa | 1998 |
Whole brain spheroid cultures as a model to study the development of nitric oxide synthase-guanylate cyclase signal transduction.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Astrocytes; Atrial Natriuretic Factor; Brain; Cell Culture Techniques; Cells, Cultured; Cyclic GMP; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Female; Guanylate Cyclase; N-Methylaspartate; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; Oxadiazoles; Phosphodiesterase Inhibitors; Pregnancy; Quinoxalines; Rats; Rats, Inbred Lew; Signal Transduction; Vasodilator Agents | 2000 |
Effect of NO donors on protein phosphorylation in intact vascular and nonvascular smooth muscles.
Topics: Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Myometrium; Nitric Oxide Donors; Nitroprusside; Oxadiazoles; Penicillamine; Phosphoproteins; Phosphorylation; Quinoxalines; Rats; S-Nitroso-N-Acetylpenicillamine; Vas Deferens | 2001 |
Relaxation and modulation of cyclic AMP production in response to atrial natriuretic peptides in guinea pig tracheal smooth muscle.
Topics: Adenylyl Cyclases; Animals; Apamin; Atrial Natriuretic Factor; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Glyburide; Guanylate Cyclase; Guinea Pigs; Histamine; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Natriuretic Peptide, C-Type; Nitroprusside; Oxadiazoles; Peptide Fragments; Peptides; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Quinoxalines; Rolipram; Trachea | 2001 |
Differential responses of newborn pulmonary arteries and veins to atrial and C-type natriuretic peptides.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cyclic GMP; Gene Expression Regulation; Guanylate Cyclase; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Natriuretic Peptide, C-Type; Nitric Oxide; Oxadiazoles; Pulmonary Artery; Pulmonary Veins; Quinoxalines; Receptors, Atrial Natriuretic Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sheep; Transcription, Genetic | 2002 |
Role of the nitric oxide-cyclic GMP-K+ channel pathway in the antinociception induced by atrial natriuretic peptide (ANP) and diclofenac.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atrial Natriuretic Factor; Charybdotoxin; Cyclic GMP; Diclofenac; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formaldehyde; Glyburide; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Pain Measurement; Potassium Channels; Quinoxalines; Rats; Rats, Wistar; Tolbutamide | 2002 |
Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Cyclic GMP; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Guanylate Cyclase; Male; Mesenteric Arteries; Mice; Mice, Inbred Strains; Mice, Knockout; Muscle Relaxation; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitrogen Oxides; Nitroglycerin; Oxadiazoles; Phenylephrine; Polysaccharides; Quinoxalines; Receptors, Atrial Natriuretic Factor; Signal Transduction; Spermine | 2003 |
High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Animals; Atrial Natriuretic Factor; Biological Transport; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 3; Enzyme Inhibitors; Guanylate Cyclase; Heart Atria; Milrinone; Molsidomine; Myocardial Contraction; Myocytes, Cardiac; Natriuretic Peptide, C-Type; Nitric Oxide Donors; Oxadiazoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazoles; Pyridines; Quinoxalines; Rabbits; Receptors, Cytoplasmic and Nuclear; Second Messenger Systems; Soluble Guanylyl Cyclase; Stroke Volume | 2004 |
Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats.
Topics: Acetylcholine; Actins; Animals; Atrial Natriuretic Factor; Body Weight; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Guanylate Cyclase; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Lung; Male; Molsidomine; Muscle, Smooth; Oxadiazoles; Piperazines; Pulmonary Artery; Purines; Quinoxalines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Systole; Vasodilation; Vasodilator Agents | 2005 |
Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
Topics: Adenoviridae; Apoptosis; Atrial Natriuretic Factor; bcl-2-Associated X Protein; Benzothiazoles; Caspase 3; Caspases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Guanylate Cyclase; Half-Life; Humans; Mutation; Ovarian Neoplasms; Oxadiazoles; Phosphorylation; Proto-Oncogene Proteins c-mdm2; Quinoxalines; RNA, Small Interfering; Serine; Signal Transduction; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein | 2006 |
Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Bridged Bicyclo Compounds; Brimonidine Tartrate; Clonidine; Coronary Circulation; Drug Synergism; Female; Heart; Heart Rate; Heptanes; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Myocardium; Perfusion; Phenoxybenzamine; Prazosin; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Drug; Yohimbine | 2006 |
Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor.
Topics: Acetylcholine; Animals; Aorta; Atrial Natriuretic Factor; Barium; Biological Factors; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Natriuretic Peptide, C-Type; Oligopeptides; Ouabain; Patch-Clamp Techniques; Potassium Channels; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Potassium-Exchanging ATPase; Spermine; Vasodilation; Vasodilator Agents | 2007 |
Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Proliferation; Cell Size; Cells, Cultured; Cyclic GMP; Fibroblasts; Intracellular Space; L-Lactate Dehydrogenase; Male; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2007 |
Two autocrine pathways to regulate cyclic GMP synthesis in cultured human retinal pigment epithelial cells.
Topics: 1-Methyl-3-isobutylxanthine; Atrial Natriuretic Factor; Autocrine Communication; Cells, Cultured; Cyclic GMP; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Guanylate Cyclase; Humans; Immunohistochemistry; NADPH Dehydrogenase; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Oxadiazoles; Phosphodiesterase Inhibitors; Pigment Epithelium of Eye; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase | 2008 |
Essential roles of the nitric oxide (no)/cGMP/protein kinase G type-Iα (PKG-Iα) signaling pathway and the atrial natriuretic peptide (ANP)/cGMP/PKG-Iα autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells.
Topics: Animals; Apoptosis; Atrial Natriuretic Factor; Autocrine Communication; Bone Marrow Cells; Cell Adhesion Molecules; Cell Line; Cell Proliferation; Cell Survival; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mice; Microfilament Proteins; Multipotent Stem Cells; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphoproteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Quinoxalines; RNA Interference; Signal Transduction | 2011 |
Cinnamyl alcohol attenuates vasoconstriction by activation of K⁺ channels via NO-cGMP-protein kinase G pathway and inhibition of Rho-kinase.
Topics: Animals; Aorta; Atrial Natriuretic Factor; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dipeptides; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Male; Methylene Blue; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Phenylephrine; Phosphorylation; Potassium Channel Blockers; Potassium Channels; Propanols; Quinoxalines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction; Vasoconstriction; Vasodilation | 2012 |
Inhibition of endogenous ouabain by atrial natriuretic peptide is a guanylyl cyclase independent effect.
Topics: Adrenal Cortex; Atrial Natriuretic Factor; Cell Line, Tumor; Cyclic GMP; Guanylate Cyclase; Humans; Ouabain; Oxadiazoles; Peptide Fragments; Quinoxalines; Radioimmunoassay; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Second Messenger Systems; Vasodilator Agents | 2021 |